Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Scandinavian Medical Solutions AS's enterprise value is €20.79 Mil.
Scandinavian Medical Solutions AS's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €0.30 Mil. Therefore, Scandinavian Medical Solutions AS's EV-to-EBITDA for today is 69.75.
The historical rank and industry rank for Scandinavian Medical Solutions AS's EV-to-EBITDA or its related term are showing as below:
FRA:K41'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.76 Med: 10.52 Max: 70.12
Current: 70.12
During the past 7 years, the highest EV-to-EBITDA of Scandinavian Medical Solutions AS was 70.12. The lowest was 5.76. And the median was 10.52.
FRA:K41's EV-to-EBITDA is ranked worse than 93.8% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 14.65
vs FRA:K41: 70.12
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Scandinavian Medical Solutions AS (FRA:K41) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Scandinavian Medical Solutions AS's PE Ratio (TTM) for today is calculated as:
Scandinavian Medical Solutions AS's share price for today is €0.373.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Scandinavian Medical Solutions AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.037.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scandinavian Medical Solutions AS EV-to-EBITDA Chart
For the Medical Devices subindustry, Scandinavian Medical Solutions AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scandinavian Medical Solutions AS EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Scandinavian Medical Solutions AS's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Scandinavian Medical Solutions AS's EV-to-EBITDA falls into.
Scandinavian Medical Solutions AS's current Enterprise Value is €20.79 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Scandinavian Medical Solutions AS's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €0.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scandinavian Medical Solutions AS (FRA:K41) has a EV-to-EBITDA of 69.75 as of Aug. 23, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Scandinavian Medical Solutions AS. This is 563% above median its historical median of 10.52. Over the past decade, Scandinavian Medical Solutions AS's EV-to-EBITDA has ranged from 5.76 to 70.12. According to the industry distribution chart, Scandinavian Medical Solutions AS ranks #484 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 93.8%.
Is Scandinavian Medical Solutions AS's EV-to-EBITDA too high?
Scandinavian Medical Solutions AS's current EV-to-EBITDA of 69.75 is 563% above median its 10-year median of 10.52. Over the past 10 years, this metric has ranged from a low of 5.76 to a high of 70.12. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.65. Scandinavian Medical Solutions AS's value of 69.75 is 376.1% above this industry median. Based on the distribution chart, Scandinavian Medical Solutions AS ranks #484 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Scandinavian Medical Solutions AS has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Scandinavian Medical Solutions AS's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Scandinavian Medical Solutions AS ranks #484 out of 516 companies for EV-to-EBITDA. This places Scandinavian Medical Solutions AS in the lower half of its industry. The industry median EV-to-EBITDA is 14.65. Scandinavian Medical Solutions AS's value of 69.75 is 376.1% above this benchmark. Historically, Scandinavian Medical Solutions AS's own EV-to-EBITDA has ranged from 5.76 to 70.12 over the past decade. While the company's 10-year median is 10.52 vs. the industry median of 14.65, Scandinavian Medical Solutions AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.65, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scandinavian Medical Solutions AS's current EV-to-EBITDA of 69.75 is 376.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Scandinavian Medical Solutions AS. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scandinavian Medical Solutions AS's current EV-to-EBITDA is 69.75, which is 563% above median its own 10-year median of 10.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scandinavian Medical Solutions AS stock overvalued right now?
Scandinavian Medical Solutions AS (FRA:K41) has a current EV-to-EBITDA of 69.75. The stock's GF Value™ is €0.78, compared to a current price of €0.37 — trading 52.2% below its estimated fair value. The current EV-to-EBITDA is 69.75, which is 563% above median its 10-year median of 10.52 and 376.1% above the Medical Devices & Instruments industry median of 14.65. Scandinavian Medical Solutions AS's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Scandinavian Medical Solutions AS (FRA:K41), the current EV-to-EBITDA is 69.75 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scandinavian Medical Solutions AS (FRA:K41) Overvalued in 2026?
Based on GuruFocus' analysis, Scandinavian Medical Solutions AS stock appears to be undervalued.
The current stock price of €0.37 is trading 52.2% below its estimated GF Value™ of €0.78.
Key valuation signals for FRA:K41:
EV-to-EBITDA: 69.75 (563% above median its 10-year median of 10.52)
GF Value™: €0.78 vs. price of €0.37 (52.2% below fair value)
Industry Position: 376.1% above the Medical Devices & Instruments median (#484 of 516)
No single metric tells the full story. See the FRA:K41 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scandinavian Medical Solutions AS is a provider of Medical Imaging equipment. The company specializes in the acquisition, quality check, and resale of high-quality pre-owned medical imaging systems. The company supplies value-added resellers and distributors in various countries with MRI, CT, PET/CT, and other diagnostic scanners. It operates the business through three business areas, Equipment Solutions, Parts Solutions and Rental Solutions. Equipment Solutions is the company's main source of revenue, which focuses on sourcing, inspecting, and selling imaging systems such as MRI, CT, PET/CT, Cath-Lab, and Mammography units.
81GF Score
Get the complete analysis for FRA:K41
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:K41 has been successfully added to your 
